Hsu Lea, Grüne Barbara, Buess Michael, Joisten Christine, Klobucnik Jan, Nießen Johannes, Patten David, Wolff Anna, Wiesmüller Gerhard A, Kossow Annelene, Hurraß Julia
Public Health Department Cologne, Infektions- und Umwelthygiene, 50667 Köln, Germany.
Institute for Occupational Medicine and Social Medicine, University Hospital, Medical Faculty, RWTH Aachen University, 52056 Aachen, Germany.
Vaccines (Basel). 2021 Nov 2;9(11):1267. doi: 10.3390/vaccines9111267.
Vaccination is currently considered the most successful strategy for combating the SARS-CoV-2 virus. According to short-term clinical trials, protection against infection is estimated to reach up to 95% after complete vaccination (≥14 days after receipt of all recommended COVID-19 vaccine doses). Nevertheless, infections despite vaccination, so-called breakthrough infections, are documented. Even though they are more likely to have a milder or even asymptomatic course, the assessment of further transmission is highly relevant for successful containment. Therefore, we calculated the real-world transmission risk from fully vaccinated patients (vaccination group, VG) to their close contacts (CP) compared with the risk from unvaccinated reference persons matched according to age, sex, and virus type (control group = CG) utilizing data from Cologne's health department.
A total of 357 breakthrough infections occurred among Cologne residents between 27 December 2020 (the date of the first vaccination in Cologne) and 6 August 2021. Of the 979 CPs in VG, 99 (10.1%) became infected. In CG, 303 of 802 CPs (37.8%) became infected. Factors promoting transmission included non-vaccinated status ( = 0.237; < 0.001), male sex ( = 0.079; = 0.049), the presence of symptoms ( = -0.125; = 0.005), and lower cycle threshold value ( = -0.125; = 0.032). This model explained 14.0% of the variance (corr. ).
The number of transmissions from unvaccinated controls was three times higher than from fully vaccinated patients. These real-world data underscore the importance of vaccination in enabling the relaxation of stringent and restrictive general pandemic control measures.
目前,接种疫苗被认为是对抗严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒最成功的策略。根据短期临床试验,完全接种疫苗后(接种所有推荐的2019冠状病毒病疫苗剂量≥14天后),预防感染的有效率估计高达95%。然而,接种疫苗后仍有感染记录,即所谓的突破性感染。尽管这些感染更有可能症状较轻甚至无症状,但评估其进一步传播对于成功控制疫情至关重要。因此,我们利用科隆市卫生部门的数据,计算了完全接种疫苗的患者(疫苗接种组,VG)与其密切接触者(CP)之间的实际传播风险,并与根据年龄、性别和病毒类型匹配的未接种疫苗的参考人员(对照组=CG)的传播风险进行了比较。
2020年12月27日(科隆首次接种疫苗的日期)至2021年8月6日期间,科隆居民共发生357例突破性感染。在疫苗接种组的979名密切接触者中,99人(10.1%)被感染。在对照组中,802名密切接触者中有303人(37.8%)被感染。促进传播的因素包括未接种疫苗状态(比值比=0.237;P<0.001)、男性(比值比=0.079;P=0.049)、出现症状(比值比=-0.125;P=0.005)和较低的循环阈值(比值比=-0.125;P=0.032)。该模型解释了14.0%的方差(校正后)。
未接种疫苗的对照组的传播人数比完全接种疫苗的患者高出三倍。这些实际数据强调了接种疫苗对于放宽严格和限制性的总体疫情防控措施的重要性。